Advertisement
Screener

Acumen Pharmaceuticals, Inc. (ABOS) Material Contracts

Acumen Pharmaceuticals, Inc. Material Contracts

Every material contract the company filed as Exhibit 10 (executive pay plans, credit agreements, supplier and indemnity agreements), newest first, with the filing's own description.

  • 2026-08-12: Form 10-Q; Exhibit 10.1; Description Acumen Pharmaceuticals, Inc. Amended and Restated 2021 Equity Incentive Plan and Forms of Stock Option Grant Notice, Award Agreement and Notice of Exercise and RSU Grant Notice and Award Agreement..
  • 2026-03-26: Form 10-K; Exhibit 10.4; Description Amended and Restated Non-Employee Director Compensation Policy.
  • 2026-03-16: Form 8-K; Exhibit 10.2; Description Form of Registration Rights Agreement, dated March 13, 2026, by and among Acumen Pharmaceuticals, Inc. and the investors party thereto.
  • 2026-03-16: Form 8-K; Exhibit 10.1; Description Form of Securities Purchase Agreement, dated March 13, 2026, by and among Acumen Pharmaceuticals, Inc. and the investors party thereto.
FiledFormExhibitDescription
2026-08-1210-Q10.1Acumen Pharmaceuticals, Inc. Amended and Restated 2021 Equity Incentive Plan and Forms of Stock Option Grant Notice, Award Agreement and Notice of Exercise and RSU Grant Notice and Award Agreement.
2026-03-2610-K10.4Amended and Restated Non-Employee Director Compensation Policy
2026-03-168-K10.2Form of Registration Rights Agreement, dated March 13, 2026, by and among Acumen Pharmaceuticals, Inc. and the investors party thereto
2026-03-168-K10.1Form of Securities Purchase Agreement, dated March 13, 2026, by and among Acumen Pharmaceuticals, Inc. and the investors party thereto
2025-08-1210-Q10.1Collaboration, Option, and License Agreement by and between the Company and JCR Pharmaceuticals Co., Ltd., dated July 15, 2025.
2025-05-1310-Q10.1Executive Employment Agreement, by and between the Registrant and James Doherty.
2025-03-2710-K10.11Lease Agreement, by and between the Registrant and Price-Poore House, LLC, dated August 1, 2024.
2025-03-2710-K10.4Amended and Restated Non-Employee Director Compensation Policy.
2024-03-2610-K10.15Loan and Security Agreement by and among the Registrant and the lenders party thereto, K2 Health Ventures LLC, as administrative agent, and Ankura Trust Company, LLC, as collateral agent, dated as of November 10, 2023.
2024-03-2610-K10.14Non-Exclusive Collaboration and License Agreement, by and between the Registrant and Halozyme, Inc., dated November 5, 2023.
2024-03-2610-K10.13Lease, by and between Registrant and DIV Washington, LLC, dated September 11, 2023.
2023-08-0810-Q10.1Amended and Restated Executive Employment Agreement, by and between the Registrant and Eric Siemers, MD.
2023-05-0910-Q10.1Amended and Restated Executive Employment Agreement, by and between the Registrant and Derek Meisner.
2023-03-2710-K10.12Lease Agreement, by and between the Registrant and Price-Poore House, LLC, dated December 1, 2022.
2023-03-2710-K10.11Lease Agreement, by and between the Registrant and Price-Poore House, LLC, dated September 28, 2022.
2023-03-2710-K10.1License Agreement, by and between the Registrant and Lonza Sales AG, dated November 2, 2022.
2022-03-2810-K10.10Employment Agreement by and between the Registrant and Russell Barton
2022-03-2810-K10.9Employment Agreement by and between the Registrant and Eric Siemers, M.D.
2022-03-2810-K10.8Executive Employment Agreement, by and between the Registrant and Matthew Zuga
2022-03-2810-K10.7Executive Employment Agreement, by and between the Registrant and Daniel O’Connell
2022-03-2810-K10.3Non-Employee Director Compensation Policy
2021-08-1610-Q10.8Employment Agreement by and between the Registrant and Matthew Zuga.

Similar stocks

Stock NameCountryMarket CapPE Ratio
Outlook Therapeutics, Inc. (OTLK)United States$0.162B-4.90
Humacyte, Inc. (HUMA)United States$0.155B-2.26
Voyager Therapeutics, Inc. (VYGR)United States$0.173B-1.99
PRECISION BIOSCIENCES INC (DTIL)United States$0.175B-3.95
Coherus Oncology, Inc. (CHRS)United States$0.182B-1.63
Tenaya Therapeutics, Inc. (TNYA)United States$0.140B-1.60
Alpha Cognition Inc. (ACOG)$0.185B-6.77
Caribou Biosciences, Inc. (CRBU)United States$0.134B-1.79
Armata Pharmaceuticals, Inc. (ARMP)United States$0.132B
Neumora Therapeutics, Inc. (NMRA)United States$0.132B-1.48